[职业间歇性肺部疾病]
1, Frankenstraße 24, 91096, Möhrendorf, Deutschland. karina.hofmann-preiss@europe.de.
Radiologie (Heidelberg, Germany)
|July 16, 2024
概括
工作场所暴露的灰尘和烟雾等物质可能会导致扩散性间歇性肺病 (ILD),其潜伏期较长. 详细的职业病史对于诊断与工作有关的ILDs至关重要,将其与异常病例区分开来.
科学领域:
- 职业医学 职业医学是专业的.
- 肺部病理学 肺部病理学
- 毒理学 毒理学 毒理学
背景情况:
- 扩散性间歇性肺病 (ILD) 可能是各种工作场所暴露的结果,包括灰尘,气体,烟雾和蒸汽.
- 这些与工作有关的ILDs的发病可能有超过30年的潜伏期.
- 与工作相关的ILD肺部高分辨率计算机断层扫描 (HRCT) 发现往往无法与其他ILD病因区分开来.
研究的目的:
- 强调职业病史在诊断间歇性肺部疾病中的重要性.
- 为了突出与工作相关的ILDs所带来的诊断挑战,由于重叠的成像模式.
- 为了强调暴露于二氧化粉和潜在的自身免疫性疾病发展之间的联系.
主要方法:
- 关于与工作有关的间歇性肺部疾病的文献综述.
- 对ILDs的诊断标准的分析.
- 职业暴露与疾病表现和病因学的相关性.
主要成果:
- 工作场所的暴露是扩散性间歇性肺病的重要原因.
- 职业病史对于准确的诊断至关重要,因为单独的HRCT模式往往是非特异性的.
- 高粉暴露越来越多地与自身免疫性疾病有关,包括肺部参与.
结论:
- 完整的职业病史对于跨学科诊断间歇性肺部疾病是不可或缺的.
- 如果不考虑职业暴露,可能导致与工作有关的ILD被错误地归类为特异性.
- 石灰尘诱导自身免疫性疾病的可能性需要对患者进行全面的评估.
相关概念视频
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.8K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.8K
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.5K
01:21Acute Respiratory Failure-II
196
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
196
01:22Chronic Obstructive Pulmonary Disease
1.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.2K
01:17Other Pulmonary Disorders
813
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
813